R&D Divisions

  1. Home
  2. R&D Divisions

CVRF IRIS Data Registry (CIDR)

CVRF IRIS Data Registry (CIDR)

To encourage research in the field of cardiovascular disease, CVRF selects researchers who have submitted research plans seeking new treatments and provides various types of support.

Research Activity

  1. IRIS-FFR A Multicenter, prospective cohort to evaluate the natural history of FFR guided Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT01366404
  2. IRIS-FFR-TANDEM A Multicenter, prospective cohort to evaluate the effect of FFR guided Percutaneous Coronary Intervention in coronary tandem lesions
    📑ClinicalTrials.gov : NCT02797561

  1. FATE-MAIN Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05829889
  2. IRIS-MAIN A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT
    📑ClinicalTrials.gov : NCT01341327
  3. MAIN COMPARE Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
    📑ClinicalTrials.gov : NCT02791412
  4. PRE-COMBAT I Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease
    📑ClinicalTrials.gov : NCT00422968
  5. PRE-COMBAT II Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis
    📑ClinicalTrials.gov : NCT01348022

  1. OCTIVUS Optical Coherence Tomography versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT03394079
  2. IRIS Imaging registry Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02792075
  3. PREVENT Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
    📑ClinicalTrials.gov : NCT02316886
  4. POST-PCI Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT03217877

  1. IRIS BioFreedom Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03190057
  2. IRIS-BIOMATRIX Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT01350778
  3. IRIS-Cilotax Evaluation of effectiveness and safety of DXR Stent in Routine Clinical Practice; A multicenter prospective observational cohort study
    📑ClinicalTrials.gov : NCT01612819
  4. IRIS-DEB Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
    📑ClinicalTrials.gov : NCT02038660
  5. IRIS DESyne X2 Evaluation of Effectiveness and Safety of DESyne X2 in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03588481
  6. IRIS-ELEMENT Evaluation of Effectiveness and Safety of PROMUS ELEMENT Stents in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT01350791
  7. IRIS-GENOUS STEMI Evaluation of Effectiveness and Safety of the GENOUS STENT in ST-Segment Elevation Myocardial Infarction
    📑ClinicalTrials.gov : NCT01348373
  8. IRIS-INTEGRITY Evaluation of Effectiveness and Safety of Resolute Integrity DES in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
    📑ClinicalTrials.gov : NCT01392846
  9. IRIS-NOBORI Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT01348360
  10. IRIS-ONYX Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02593994
  11. IRIS-Orsiro Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02039739
  12. IRIS Skypoint a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05981911
  13. IRIS-Premier Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02060968
  14. IRIS-PRIME Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT01348399
  15. IRIS-ROTA Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03427996
  16. IRIS Sierra Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT03967158
  17. IRIS-Tansei Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT04443530
  18. IRIS-SYNERGY Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02720419
  19. IRIS Synergy XD And Megatron Evaluation of Effectiveness and Safety of Synergy™ XD Stent and Synergy Megatron™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT05044273
  20. IRIS Coroflex ISAR NEO registry Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT06177743
  21. IRIS-ULTIMASTER Evaluation of Effectiveness and Safety of Ultimaster® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02719106
  22. IRIS-Xpedition/Alpine/Sierra Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT02042300
  23. K-XIENCE Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT01350869
  24. DESSIAN Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population
    📑ClinicalTrials.gov : NCT00997711

  1. DEFINE-DM Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05831085
  2. Asan-MV Registry Asan Multivessel Registry
    📑ClinicalTrials.gov : NCT02039752
  3. BEST Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease
    📑ClinicalTrials.gov : NCT00997828

  1. IRIS-CTO Registry Chronic Total Occlusion Registry
    📑ClinicalTrials.gov : NCT04041921
  2. DECISION-CTO Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion
    📑ClinicalTrials.gov : NCT01078051

  1. ASAN-MI Registry Asan Medical Center Myocardial Infarction Registry
    📑ClinicalTrials.gov : NCT03412435

  1. TAILORED-CHIP TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI
    📑ClinicalTrials.gov : NCT03465644
  2. EPIC-CAD Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
    📑ClinicalTrials.gov : NCT03718559
  3. RENOVATE Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT04258488
  4. PROTECT-HBR Potassium-Competitive Acid Blocker versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
    📑ClinicalTrials.gov : NCT04416581
  5. TICAKOREA Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
    📑ClinicalTrials.gov : NCT02094963
  6. OPTIMA Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
    📑ClinicalTrials.gov : NCT02319941
  7. FIMA-DEFER Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease
    📑ClinicalTrials.gov : NCT01384747
  8. PRIDE Effectiveness of Clopidogrel Resinate in PCI
    📑ClinicalTrials.gov : NCT01349777
  9. STABLE Statin and Atheroma Vulnerability Evaluation
    📑ClinicalTrials.gov : NCT00997880
  10. DES-LATE Optimal Duration of Clopidogrel Therapy after Drug-Eluting Stent Implantation to Reduce Late Coronary Arterial Thrombotic Events
    📑ClinicalTrials.gov : NCT01186146

  1. Variant ICD Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
    📑ClinicalTrials.gov : NCT02845531

  1. ENAVO-TAVR ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT05672836
  2. ASAN-AVR Registry ASAN Medical Center Aortic Valve Replacement Registry
    📑ClinicalTrials.gov : NCT03298178
  3. SENTINEL pilot Registry The Sentinel Registry
    📑ClinicalTrials.gov : NCT05217888
  4. Asian TAVR Registry The Asian Transcatheter Aortic Valve Replacement Registry
    📑ClinicalTrials.gov : NCT02308150
  5. ADAPT-TAVR Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT03284827

  1. HOWTO-BRS Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT03175523
  2. BVS Late Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
    📑ClinicalTrials.gov : NCT02939872
  3. IRIS-BVS Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT02622100